Kusajili – Clinical trials directory

Result of your search per sponsor: Chevallier Patrice, MD

Woman and Man Max 99 years
Chevallier Patrice, MD Update Il y a 4 ans

Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ The purpose of this study is to determine whether fractionated RIT with Epratuzumab and radiolabeled Epratuzumab are effective in the treatment of relapsing or refractory ALL.

Country France
organs None
Specialty None

unknown

More information